Grant

Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)

CountryUnited States
Deadline2027-07-02 (222 days left)
Published2024-12-06
SectorsHealth & life sciences
SourceGrants.gov (US)

Summary

Funding opportunity RFA-TR-25-002. CFDA: 93.350

The buyer, the value, the full description and the link to the official notice are available with a free account.